These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9562141)

  • 1. HIV wasting syndrome: treatment update.
    Balog DL; Epstein ME; Amodio-Groton MI
    Ann Pharmacother; 1998 Apr; 32(4):446-58. PubMed ID: 9562141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic management of human immunodeficiency virus wasting syndrome.
    Badowski M; Pandit NS
    Pharmacotherapy; 2014 Aug; 34(8):868-81. PubMed ID: 24782295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megestrol acetate vs cyproheptadine in the treatment of weight loss associated with HIV infection.
    Summerbell CD; Youle M; McDonald V; Catalan J; Gazzard BG
    Int J STD AIDS; 1992; 3(4):278-80. PubMed ID: 1504160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human growth hormone for AIDS-associated wasting.
    Windisch PA; Papatheofanis FJ; Matuszewski KA
    Ann Pharmacother; 1998 Apr; 32(4):437-45. PubMed ID: 9562140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-agent/combination therapy of human immunodeficiency virus-related wasting.
    Wanke C
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):98-103. PubMed ID: 9625391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megestrol acetate: promises and pitfalls.
    Farrar DJ
    AIDS Patient Care STDS; 1999 Mar; 13(3):149-52. PubMed ID: 10375262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting.
    Grinspoon S; Corcoran C; Lee K; Burrows B; Hubbard J; Katznelson L; Walsh M; Guccione A; Cannan J; Heller H; Basgoz N; Klibanski A
    J Clin Endocrinol Metab; 1996 Nov; 81(11):4051-8. PubMed ID: 8923860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of dronabinol in the treatment of weight loss associated with HIV and AIDS.
    Badowski ME; Perez SE
    HIV AIDS (Auckl); 2016; 8():37-45. PubMed ID: 26929669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options for HIV-associated bodyweight loss. A risk-benefit analysis.
    Stosor V; Roenn JV
    Drug Saf; 1997 Nov; 17(5):290-302. PubMed ID: 9391773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and treatment of endocrine disorders in the HIV-infected patient.
    Corcoran CP; Grinspoon S
    J Int Assoc Physicians AIDS Care; 1998 Feb; 4(2):10-4, 34. PubMed ID: 11365082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weight loss update.
    PI Perspect; 1996 Nov; (No 20):18-9. PubMed ID: 11363968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simply stated...are people still wasting?
    Res Initiat Treat Action; 1998 Aug; 4(5):15. PubMed ID: 11365707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trials update in human immunodeficiency virus wasting.
    Muurahainen N; Mulligan K
    Semin Oncol; 1998 Apr; 25(2 Suppl 6):104-11. PubMed ID: 9625392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weight loss and wasting in patients infected with human immunodeficiency virus.
    Grinspoon S; Mulligan K;
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S69-78. PubMed ID: 12652374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The HIV wasting syndrome.
    Reiter GS
    AIDS Clin Care; 1996 Nov; 8(11):89-91, 93, 96. PubMed ID: 11363990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wasting syndrome--affordable treatments.
    James JS
    AIDS Treat News; 1995 Jul; (no 226):6-7. PubMed ID: 11362615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection.
    Mulligan K; Grunfeld C; Hellerstein MK; Neese RA; Schambelan M
    J Clin Endocrinol Metab; 1993 Oct; 77(4):956-62. PubMed ID: 8408471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches to the AIDS Wasting Syndrome.
    Corcoran C
    Posit Dir News; 1998; 10(2):24-7. PubMed ID: 11365549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
    Cuerda C; Zugasti A; Bretón I; Camblor M; Miralles P; García P
    Nutr Clin Pract; 2005 Feb; 20(1):93-7. PubMed ID: 16207650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.